2021-01-03,b'$ALDX https://t.co/RtXWUbsiRM Aldeyra Therapeutics Inc The statistical model is forecasting the market value of this company has a neutral short term outlook and has weak long term fundamentals #money #bitcoin #personalfinance'
2021-01-03,b'@Biotech2051 @bob4punk $aldx be acquired by J&amp;J'
2021-01-02,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-02,"b'$ALDX option volume was 10X normal on Thursday with 2,962 contracts. Call volume was 3% and put volume was 97%. https://t.co/DyiVizV4tt'"
2021-01-02,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-02,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-02,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-02,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-02,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-02,b'$ALDX\n\nBig buys from funds and insiders\n\nBig pipeline with many products in Phase 3\n\nLots of Cash on hand\n\nStable stock price over the past 5 years+'
2021-01-01,b'@jq1234t @MSollender $aldx is very promising'
2021-01-01,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-01,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-01,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-01,b'$ALDX Investors Purchase Large Volume of Put Options on Aldeyra Therapeutics https://t.co/NKb5pRLCDo https://t.co/6YYxgXHUqm'
2021-01-01,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-01,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-01,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-01,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-01,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2020-12-31,b'Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts to look forward to:\n\n$AGLE $ALDX $AMGN $ANAB $ARQT $ASLN $BTAI $CALA $CNCE $ERYP $FOLD $FPRX $IMTX $KALV $MORF $MRSN $OTIC $PLRX $SAGE $SRRK $TVTX $WVE $ZYME https://t.co/xQ7CFv6dRw'
2020-12-31,"b""Slightly worried that $ALDX has not put out a press release regarding the 20 patient run-in results, which they guided would happen before YE. If results are positive, they would've released premarket. If results are negative, it would make sense to release after hours today."""
2020-12-30,b'Just grabbed 100 $ALDX thanks to @BigBucksBryant - not investment advice https://t.co/1SugkvTOmN'
2020-12-30,b'RT @JoseRicaurteJ: \xf0\x9f\x92\xb0 #winner \n$ALDX \n\n#m\xc3\xa9todoinsiders https://t.co/g40biGcnHZ'
2020-12-30,b'Morning watch list...\n$CKPT $SHIP $ALDX'
2020-12-30,b'$CVX CEO Release Details of Pending Merger With Unnamed Nasdaq Traded Stock Following Talks In NYC\nhttps://t.co/Mv3xmUJu9A\n\n$AQ $APU $APTS $APTO $APTI $ALDX $DYNC $RIF $JAX $KOP $TRLPF $SNSS $NJMC $GWTI $FETM $SVRA $SANW $RM'
2020-12-30,b'\xf0\x9f\x92\xb0 #winner \n$ALDX \n\n#m\xc3\xa9todoinsiders https://t.co/g40biGcnHZ'
2020-12-28,b'$ALDX bullish falling wedge nearing apex.'
2020-12-28,b'RT @snicobio: Adding $ALDX here before 20 patient run-in results YE.'
2020-12-28,b'Adding $ALDX here before 20 patient run-in results YE.'
2020-12-28,b'20 DMA Support today: $MRO $AMWL $PK $SPYV $ALDX $TEN $HMLP $VNDA $PCI $AMP $WPX $EHTH $INVH $LBAI $TNAV $FAMI $V $DHT $CL $PINS ... https://t.co/deOpbNqdR6'
2020-12-28,b'$OSTK CEO to approve release of updated info on buyout talks happening in Phoenix\nhttps://t.co/Mv3xmUJu9A\n\n$ALDX $DYNC $RIF $JAX $KOP $TRLPF $SNSS $NJMC $GWTI $FETM $SVRA $SANW $RM'
2020-12-27,b'RT @Romeo_Trading: https://t.co/prxQf1jYC4\n\nStock Watchlist for 12/14/2020\n$ADT $ALDX $AMRN $ARCO $AREC $ASMB $CAPR $CRK $CYH $DBVT $DNK $E\xe2\x80\xa6'
2021-01-07,"b'RT @snicobio: $ALDX CEO Todd Brady is really impressive. Anyone listening to this CC should be giddy.\n\nClearly excited about their science,\xe2\x80\xa6'"
2021-01-07,"b'RT @snicobio: $ALDX CEO Todd Brady is really impressive. Anyone listening to this CC should be giddy.\n\nClearly excited about their science,\xe2\x80\xa6'"
2021-01-07,b'$ALDX long term for me here.. eye care swing.. slapping 25$ tgt :)'
2021-01-07,"b'RT @snicobio: @sentivcapital Always liked $KALA, but $ALDX results make me wonder whether there could be consolidation to a single agent in\xe2\x80\xa6'"
2021-01-07,"b'$ALDX Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer\xe2\x80\x99s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial https://t.co/VN5dvk3c8U'"
2021-01-07,"b'$ALDX data are not appreciated by the market, imo. Thanks for that opportunity! \xf0\x9f\x99\x8f'"
2021-01-07,b'$ALDX - the insignificant improvement in Ocular Discomfort says it All - that\xe2\x80\x99s what I treat.'
2021-01-07,"b'$ALDX  announces top-line results from run-in cohort in Tranquility study, stock jumps +3.50% https://t.co/5ckAoNl9Gu'"
2021-01-07,"b'RT @pete66900309: @Daycap1 $aldx very impressive data , this is a highly undervalued gem that has managed to be under radar'"
2021-01-07,"b'RT @snicobio: $ALDX CEO Todd Brady is really impressive. Anyone listening to this CC should be giddy.\n\nClearly excited about their science,\xe2\x80\xa6'"
2021-01-07,b'$ALDX \xf0\x9f\x91\x8d'
2021-01-07,"b'@sentivcapital Always liked $KALA, but $ALDX results make me wonder whether there could be consolidation to a single agent in reproxalap for both the acute and chronic DED settings.'"
2021-01-07,"b'RT @JacobPlieth: $ALDX reproxalap sales forecasts by indication, via @evaluatepharma Conjunctivitis data in Mar 2019; dry eye run-in cohort\xe2\x80\xa6'"
2021-01-07,"b'@Daycap1 $aldx very impressive data , this is a highly undervalued gem that has managed to be under radar'"
2021-01-07,"b'RT @snicobio: $ALDX CEO Todd Brady is really impressive. Anyone listening to this CC should be giddy.\n\nClearly excited about their science,\xe2\x80\xa6'"
2021-01-07,b'RT @pete66900309: $aldx https://t.co/VM7xrw1cfm'
2021-01-07,b'$NIU +6.8% (reports Q4 e-scooter sales increased 40.9%)  \n\n$ALDX +5.8% (announces positive top-line symptom and sign results from run-in cohort of phase 3 tranquility trial in dry eye disease)'
2021-01-07,b'$ALDX Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease | Business Wire https://t.co/Jv2t5xFXaj'
2021-01-07,"b'RT @JPRATHGEBER: Equity day trade algo focus list $OGEN, $CBAT, $FTFT, $CNET, $RELL, $SUNW, $ALDX, $SRAX, $EBON, $CHEK, $NXTD, $CCNC, $ENG,\xe2\x80\xa6'"
2021-01-07,"b'Equity day trade algo focus list $OGEN, $CBAT, $FTFT, $CNET, $RELL, $SUNW, $ALDX, $SRAX, $EBON, $CHEK, $NXTD, $CCNC, $ENG, $LIVX, $SNGX, $OPTT, $JAGX \n \n Brought to you by https://t.co/1LSFP6fCKG'"
2021-01-07,b'$ALDX: Aldeyra Therapeutics announces positive top-line symptom and sign results from run-in cohort of phase 3... https://t.co/3TGGt9eSj5'
2021-01-07,"b""Aldeyra's reproxalap improves dry eye disease symptoms, run-in cohort shows $aldx https://t.co/ZOj1hMyxKE"""
2021-01-07,b'RT @sentivcapital: $ALDX Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILIT\xe2\x80\xa6'
2021-01-07,"b'$ALDX CEO Todd Brady is really impressive. Anyone listening to this CC should be giddy.\n\nClearly excited about their science, deeply intimate with the data, and genuinely passionate about the potential of Reproxalap for patients.'"
2021-01-07,"b""Aldeyra's reproxalap improves dry eye disease symptoms, run-in cohort shows $ALDX https://t.co/8HtEsqajq4"""
2021-01-07,"b""RT @BioStocks: $ALDX Phase 3 INVIGORATE study topline data 1H'21"""
2021-01-07,"b'RT @Daycap1: $ALDX - potential for 2-day vs. 28 day Ph3, that is huge for timing and cost of Ph3. Looking forward to the mkt realizing the\xe2\x80\xa6'"
2021-01-07,"b""$ALDX NEW ARTICLE : Aldeyra's reproxalap improves dry eye disease symptoms, run-in cohort shows https://t.co/dWehqIwEDF Get all the latest $ALDX related news here : https://t.co/vZNiupdoiD"""
2021-01-07,"b'$ALDX - potential for 2-day vs. 28 day Ph3, that is huge for timing and cost of Ph3. Looking forward to the mkt realizing the price mismatch of this opportunity not only in dry eye, but also allergic conjunctivitis. Game changing year for $ALDX'"
2021-01-07,"b""$ALDX - Aldeyra's reproxalap improves dry eye disease symptoms, run-in cohort shows https://t.co/60qhMSHbgh"""
2021-01-07,b'$ALDX is a prime candidate for\xe2\x80\xa6'
2021-01-07,"b'Burning, Stinging, Ocular Discomfort and Schirmers - no initial difference between $ALDX Repraxolap &amp; Placebo- why not wait for more treatment time? https://t.co/SvWFh6LoxZ'"
2021-01-07,b'@sentivcapital @avidresearch @snicobio If I was a betting man I would say they drop the whole RASP primary endpoint and go with redness $ALDX'
2021-01-07,b'RT @MSollender: Happy New Year!  Hope you all had a wonderful and relaxing holiday season.  Time to do it all again!\n\nSome 1Q21 catalysts t\xe2\x80\xa6'
2021-01-07,"b'Is $ALDX an acquisition target? Reproxalap in the hands of large pharma could easily be a blockbuster.\n\nXiidra and Eysuvis in 1 drug, with better tolerability and no IOP concerns, respectively.\n\n$260M market cap???? With a deep pipeline???? What????'"
2021-01-07,"b'$ALDX Aldeyra Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/KGjXi2OKvJ'"
2021-01-07,"b""$ALDX shouldn't mess around with RASP and should just go with ocular redness as its Ph3 signs endpoint.\n\nTopline run-in results this morning are impressive."""
2021-01-07,b'$ALDX (+5.8%) announces positive top-line symptom and sign results from run-in cohort of phase 3 tranquility trial in dry eye disease'
2021-01-07,"b'RT @JacobPlieth: $ALDX reproxalap sales forecasts by indication, via @evaluatepharma Conjunctivitis data in Mar 2019; dry eye run-in cohort\xe2\x80\xa6'"
2021-01-07,"b'$ALDX reproxalap sales forecasts by indication, via @evaluatepharma Conjunctivitis data in Mar 2019; dry eye run-in cohort results today, two ph3 studies starting Q1 https://t.co/VFe34vLEXJ'"
2021-01-07,b'$ALDX (+5.7% pre) Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease - BW\n\nhttps://t.co/sNNjJs6b2l'
2021-01-07,"b'Filing Alert, FORM 8-K [Press/News Current Report] available.  $ALDX #AldeyraTherapeutics, Inc  https://t.co/47e3lz3jY8'"
2021-01-07,"b'$ALDX / Aldeyra Therapeutics files form 8-K - Regulation FD Disclosure, Financial Statements and Exhibits, Other Events -  8-K https://t.co/RhAPcalOZF'"
2021-01-07,"b'$ALDX [15s. delayed] filed form 8-K on January 07, 07:51:00: Item7.01: Regulation FD https://t.co/4pG4xxUoBJ'"
2021-01-07,b'$aldx https://t.co/VM7xrw1cfm'
2021-01-07,"b""$ALDX Phase 3 INVIGORATE study topline data 1H'21"""
2021-01-07,b'RT @MSollender: $ALDX Slides: https://t.co/Pl78m1hbvO'
2021-01-07,b'$ALDX Slides: https://t.co/Pl78m1hbvO'
2021-01-07,b'Aldeyra announces top-line results from run-in cohort in Tranquility study\n$ALDX'
2021-01-07,b'RT @MSollender: $ALDX Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY T\xe2\x80\xa6'
2021-01-07,"b'$ALDX ""editing"" my previous tweet: Didn\'t see that redness was stat sig. While Schirmer is directionally positive for now, this is only the run in phase in 23 pts, full study should see Schirmer positive as well'"
2021-01-07,b'RT @MSollender: $ALDX Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY T\xe2\x80\xa6'
2021-01-07,b'$ALDX NEW ARTICLE : Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease https://t.co/tTDBer2m88 Get all the latest $ALDX related news here : https://t.co/vZNiupdoiD https://t.co/vylh5G6JKF'
2021-01-07,"b'$ALDX Statistical Significance of Reproxalap Over Vehicle Achieved for Ocular Redness, an FDA-Approvable Sign, and Clinical Symptoms of Ocular Dryness and Discomfort'"
2021-01-07,b'$ALDX Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease\n\nhttps://t.co/yDY5I8Ldgo'
2021-01-07,b'RT @TonyFauci2: @kamal_moghrabi Yes  a \xe2\x80\x9cwhole new\xe2\x80\x9d way to fail in inflammatory eye disease $ALDX is past prologue? https://t.co/u7UDcHO2te'
2021-01-07,"b'$ALDX [15s. delayed]: Issued Press Release on January 07, 07:00:00: Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease https://t.co/pabNuEDiVV'"
2021-01-07,b'RT @sentivcapital: $ALDX Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILIT\xe2\x80\xa6'
2021-01-07,b'RT @sentivcapital: $ALDX Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILIT\xe2\x80\xa6'
2021-01-07,b'$ALDX Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease'
2021-01-07,b'$ALDX Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease\nhttps://t.co/5Rs9K5hrFa'
2021-01-07,b'https://t.co/RtXWUbsiRM Aldeyra Therapeutics Inc The predictive algorithm concludes that this companie s stock price value won t see its price moving much shortly with a pessimistic long term persective $ALDX #entrepreneur #motivation #marketing'
2021-01-07,"b'$ALDX Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer\xe2\x80\x99s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial | Business Wire https://t.co/VTUmmEtrsE'"
2021-01-07,"b'@lblegend33 @BioStocks $ALDX this just seems like a partial data analysis update and not a full trial readout, right?'"
2021-01-07,b'RT @TonyFauci2: @kamal_moghrabi Yes  a \xe2\x80\x9cwhole new\xe2\x80\x9d way to fail in inflammatory eye disease $ALDX is past prologue? https://t.co/u7UDcHO2te'
2021-01-07,b'After-Hours Movers 01/06: \n\n$TLRY $ORTX $ALDX Higher; $PLYA DMTK $BLNK Lower more.\n\nhttps://t.co/EDg2BVLh7k'
2021-01-07,b'@kamal_moghrabi Yes  a \xe2\x80\x9cwhole new\xe2\x80\x9d way to fail in inflammatory eye disease $ALDX is past prologue? https://t.co/u7UDcHO2te'
2021-01-07,b'@spauldingIII what will you know ? limited data on limited cohort? Little for $ALDX to gain - everything to lose'
2021-01-07,b'https://t.co/RtXWUbsiRM Aldeyra Therapeutics Inc The network assessed that this stock price has a neutral short term outlook and has weak long term fundamentals $ALDX #financialfreedom #realestate #entrepreneurship'
2021-01-07,"b'@TonyFauci2 If you have no position, why have you posted 6 negative tweets on $ALDX post close today?'"
2021-01-07,b'Wonder why on Dry Eye? $ALDX - another fail? https://t.co/u7UDcI5DRO https://t.co/CjtQ6zQCyA'
2021-01-07,"b'RT @MaisaCorp: $ALDX Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer\xe2\x80\x99s Test Res\xe2\x80\xa6'"
2021-01-06,"b'$ALDX Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer\xe2\x80\x99s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial'"
2021-01-06,"b'Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer\xe2\x80\x99s Test Re.. $ALDX https://t.co/4ytqT7O9xX'"
2021-01-06,b'@MSollender AH activity seems to be favoring results $aldx .. holding good position into 2021'
2021-01-06,"b'RT @snicobio: Slightly worried that $ALDX has not put out a press release regarding the 20 patient run-in results, which they guided would\xe2\x80\xa6'"
2021-01-06,b'@MSollender No mention of RASP levels in this announcement? Will have to see \xf0\x9f\xa4\x94 $ALDX'
2021-01-06,"b""$ALDX so tomorrow's call will NOT discuss RASP levels (objective sign, and primary endpoint) then? Or will they? \xf0\x9f\xa4\x94 https://t.co/iFzpFX1dq7 https://t.co/NcfMkUL4fF"""
2021-01-06,b'$ALDX...Yep... there is the .69 runup..... https://t.co/3DTpvzFaDU'
2021-01-06,"b'RT @MSollender: $ALDX to discuss top-line symptom, redness, and Schirmer\xe2\x80\x99s test results from the run-in cohort of the Phase 3 TRANQUILITY c\xe2\x80\xa6'"
2021-01-06,"b""@MSollender Just searched a bit, and it doesn't look good on these pre data announcements from $ALDX"""
2021-01-06,"b'$ALDX large amount of Jan $5 puts recently traded, will be interesting to see data tomorrow'"
2021-01-06,"b'RT @MSollender: $ALDX to discuss top-line symptom, redness, and Schirmer\xe2\x80\x99s test results from the run-in cohort of the Phase 3 TRANQUILITY c\xe2\x80\xa6'"
2021-01-06,"b'RT @MSollender: $ALDX to discuss top-line symptom, redness, and Schirmer\xe2\x80\x99s test results from the run-in cohort of the Phase 3 TRANQUILITY c\xe2\x80\xa6'"
2021-01-06,"b'$ALDX Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer\xe2\x80\x99s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial https://t.co/XlPwcLNNiH'"
2021-01-06,"b'$ALDX They always press release the day before data, for those wondering'"
2021-01-06,b'$aldx news soon'
2021-01-06,"b'$ALDX to discuss top-line symptom, redness, and Schirmer\xe2\x80\x99s test results from the run-in cohort of the Phase 3 TRANQUILITY clinical trial in patients with dry eye disease. \n\nThe main cohort of TRANQUILITY is expected to begin enrollment in February 2021 https://t.co/BKPCcqaeVw'"
2021-01-06,"b'@zbiotech Not sure , if these are good or bad results if they are setting up a call exclusively .. own a big position $aldx .. https://t.co/BwKgzrLsmQ'"
2021-01-06,b'$ALDX https://t.co/torznUvsnS'
2021-01-06,b'RT @BioStocks: Phase 3 TRANQUILITY trial $ALDX'
2021-01-06,b'Phase 3 TRANQUILITY trial $ALDX https://t.co/sXxjdlvTtP'
2021-01-06,"b'$ALDX data tomorrow morning, 8am est call'"
2021-01-06,b'$ALDX ...wonder if we get a bit of a runup into the cc https://t.co/g3T5PPNkwG'
2021-01-06,"b'$ALDX... to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer\xe2\x80\x99s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial.'"
2021-01-06,"b'$ALDX Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer\xe2\x80\x99s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial\nhttps://t.co/KEp1rANYaU'"
2021-01-06,b'$aldx 12/16/2020Berenberg BankInitiated CoverageBuy$32.00'
2021-01-06,"b""$ALDX - Aldeyra Therapeutics's Consecutive days of price move just crossed below 0, in the past this led to a decrease in price [https://t.co/2oNnYBsPC9] https://t.co/PJKnfKemsa"""
2021-01-06,b'RT @CatalystWatcher: Bought some $ALDX going into year end for this potential catalyst: Reproxalap for DED preliminary RASP assay data'
2021-01-06,b'$HALB to disclose advance merger negotiations to begin this week\nhttps://t.co/fK8PPZ6hwp\n\n$ALDX $DYNC $RIF $JAX $KOP $TRLPF $SNSS $NJMC $GWTI $FETM $SVRA $SANW $RM'
